Jae Sevelius, PhD

Title(s)Professor, Medicine
SchoolSchool of Medicine
Address550 16th. Street
San Francisco CA 94158
Phone415-502-1000 ext. 14622
ORCID ORCID Icon0000-0002-8318-038X Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoPostdoctoral Research ScholarBehavioral Medicine
    University of MissouriPhDClinical Psychology
    University of OregonPre-doctoral clinical internship (APA-accredited)Clinical Psychology, Psychological Assessment
    University of MissouriMAGender Studies
    University of FloridaBachelor of SciencePsychology
    Multidisciplinary Association for Psychedelic StudiesCertificate2022MDMA-assisted psychotherapy
    University of California, San FranciscoCertificate2018Diversity, Equity, and Inclusion Champion Training
    California Institute for Integral StudiesCertificate2016Psychedelic Therapies and Research
    Collapse Awards and Honors
    University of California, San Francisco2021Chancellor Award for LGBTQI Leadership
    American Psychological Association - Division 35 Section 4 - Lesbian, Bisexual, & Trans Concerns 2021Laura Brown Award
    UCSF School of Medicine2020Genentech Midcareer Development Award
    American Psychological Association, Committee on Sexual Orientation and Gender Diversity2018Outstanding Achievement Award
    CREDITS - Center for Research, Excellence, and Diversity in Team Science2017Strengthening Team Science in California
    Gladstone Center for AIDS Research, UCSF2016Early Career Research Excellence Award - Behavioral Science
    CORO, UCSF2015UCSF CORO Faculty Leadership
    Center for AIDS Prevention Studies, UCSF2010Innovative Dissemination Award

    Collapse Overview 
    Collapse Overview
    Jae Sevelius, PhD, (they/them) is Professor of Medicine and Director of the UCSF Center for AIDS Prevention Studies (CAPS; P30MH062246) and the Center of Excellence for Transgender Health.

    Dr. Sevelius is a licensed clinical psychologist and community-engaged researcher whose portfolio of NIH-funded behavioral health research focuses on intervention science and the investigation of risk and protective factors in transgender and gender diverse communities, elucidating and intervening upon relationships between intersectional stigma, gender affirmation, and health-related behaviors and outcomes.

    Most recently, Dr. Sevelius' research has focused on developing, testing, and disseminating peer-led interventions to promote sexual health and resilience among transgender people by addressing intersectional stigma among transgender women of color and those affected by HIV in the San Francisco Bay Area and in São Paulo, Brazil.

    Dr. Sevelius is also a dedicated mentor of early-stage investigators, with a focus on those with backgrounds and identities that are under-represented in academic medicine. They are a passionate advocate for transforming academic institutions to create environments where diversity is truly celebrated, equity is non-negotiable, and inclusion follows naturally from a culture of belonging.

    Collapse Research 
    Collapse Research Activities and Funding
    Center for AIDS Prevention Studies (CAPS)
    NIH/NIMH P30MH062246Sep 1, 2021 - Aug 31, 2026
    Role: Principal Investigator and Center Director
    Description: CAPS will continue to provide critical support to a cadre of world-class scientists who push disciplinary boundaries. This will be accomplished via an agile infrastructure of research cores designed to ignite scientific innovation and high-impact research with the depth and breadth necessary to reach global indicators for ending the epidemic.
    Ujima Mentoring Program
    NIH/NIMH P30 MH062246-21W7Sep 1, 2021 - Aug 31, 2023
    Description: The major goals of the Ujima Mentoring Program are to increase Ujima scholars’ capacity to conduct high-impact research to address HIV-related health inequities in Black communities, provide research funding and mentoring for scholars’ proposed projects, and support the development of scholars’ research careers and through training, mentoring, and networking opportunities.
    Mentoring clinical investigators in patient-oriented research on substance use and HIV
    NIH K24DA051328Jul 15, 2020 - Jun 30, 2025
    Role: Principal Investigator
    Description: The overall aim of this Midcareer Development Award proposal is to develop and implement intersectional approaches to mentoring and patient-oriented research focused on HIV prevention and treatment interventions with transgender and gender diverse people who use substances.
    Reducing Intersectional Stigma among High-Risk Women in Brazil to Promote Uptake of HIV Testing and PrEP
    NIH R01MH121308Aug 14, 2019 - May 31, 2024
    Role: Multi Principal Investigator (MPI: Lippman, Sheri)
    Description: The overall objective of this project is to test the efficacy of a multi-level intervention designed to address intersectional stigma to improve the HIV prevention continuum among transgender women in Brazil.
    A couples-based approach to HIV prevention for transgender women and their male partners
    NIH/NIMH R01MH115765Jul 15, 2018 - Apr 30, 2023
    Role: Multi-Principal Investigator
    Mapping perceptions of PrEP use in trans women and barriers to care in providers to inform intervention development
    NIH/NIMH R21MH110340Apr 11, 2017 - Mar 10, 2019
    Role: Multi-Principal Investigator
    Improving engagement in HIV care for high-risk women
    NIH R01MH106373Sep 8, 2015 - Jun 30, 2020
    Role: Principal Investigator
    Culturally relevant intervention development for incarcerated transgender women
    NIH R34DA038541Sep 15, 2014 - Aug 31, 2017
    Role: Principal Investigator
    SHEROES: Cuturally relevant sexual risk reduction among high-risk women
    NIH R34MH102109Sep 26, 2013 - Jun 30, 2016
    Culturally Relevant HIV Prevention for High-Risk Women
    NIH K08MH085566Jan 1, 2009 - Feb 28, 2014
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications
    Collapse Faculty Mentoring
    Collapse Academic Senate

    Collapse Featured Content 
    Collapse Twitter
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Bridging the gap between practice guidelines and the therapy room: Community-derived practice adaptations for psychological services with transgender and gender diverse adults in the central United States. Professional Psychology: Research and Practice. Advance online publication. 2022. Hope, D. A., Holt, N. R., Woodruff, N., Mocarski, R., Meyer, H. M., Puckett, J. A., Eyer, J., Craig, S., Feldman, J., Irwin, J., Pachankis, J., Rawson, K. J., Sevelius, J., & Butler, S. View Publication.
    2. Adapting and implementing an evidence-based reentry intervention for incarcerated transgender women: Lessons learned. (in press). Joint Special Issue on Transgender Health and Corrections, Transgender Health and Journal of Correctional Health Care. 2022. 84. Sevelius, JM, Castro, D, Warri, V, Moreta Avila, L, Chakravarty, D, Zamudio-Haas, S, Kramer, K, Zack, B.
    3. Randomized Controlled Trial of Healthy Divas: A Gender-Affirming, Peer-Delivered Intervention to Improve HIV Care Engagement among Transgender Women Living with HIV. Journal of Acquired Immune Deficiency Syndromes. (in press). 2022. Sevelius JM, Dilworth SE, Reback CJ, Chakravarty D, Castro D, Johnson MO, McCree B, Jackson A, Mata RP, Neilands TB.
    4. The ethical imperative to reduce HIV stigma through community-engaged, status-neutral interventions designed with and for transgender women of colour. [Special Issue: Getting to the Heart of Stigma]. Journal of the International AIDS Society. (in press). 2022. 83. Gamarel KE, Rebchook G, McCree BM, Connolly M, Reyes LA, Sevelius JM.
    5. Applying intersectional stigma in public health research and praxis. American Journal of Public Health. (in press). 2022. Sievwright, K, Stangl, AL, Nyblade, L, Lippman, SA, Veras, MA, Zamudio-Haas, S, Smith, K, Pachankis, J, Logie, C, Poteat, T, Rao, D, Mena, L, Kalichman, S, Weiser, S, Roebuck, N, Greenberg, A, Brooks, R, Sevelius, JM.
    6. Peer Navigation to Support Transgender Women's Engagement in HIV Care: Findings from the Trans Amigas Pilot Trial in São Paulo, Brazil. AIDS Behav. 2022 Feb 04. Lippman SA, Sevelius JM, Saggese GSR, Gilmore H, Bassichetto KC, de Barros DD, de Oliveira RB, Maschião LF, Chen D, de Sousa Mascena Veras MA. PMID: 35119537.
      View in: PubMed   Mentions:
    7. Do Ask, Tell, and Show: Contextual Factors Affecting Sexual Orientation and Gender Identity Disclosure for Sexual and Gender Minority People. LGBT Health. 2022 Feb-Mar; 9(2):73-80. Suen LW, Lunn MR, Sevelius JM, Flentje A, Capriotti MR, Lubensky ME, Hunt C, Weber S, Bahati M, Rescate A, Dastur Z, Obedin-Maliver J. PMID: 35073205; PMCID: PMC8968837.
      View in: PubMed   Mentions:
    8. Exploring barriers and facilitators to PrEP use among transgender women in two urban areas: implications for messaging and communication. BMC Public Health. 2022 01 06; 22(1):17. Bass SB, Kelly PJ, Brajuha J, Gutierrez-Mock L, Koester K, D'Avanzo P, Sevelius J. PMID: 34991548; PMCID: PMC8740429.
      View in: PubMed   Mentions:
    9. Uptake, Retention, and Adherence to Pre-exposure Prophylaxis (PrEP) in TRIUMPH: A Peer-Led PrEP Demonstration Project for Transgender Communities in Oakland and Sacramento, California. J Acquir Immune Defic Syndr. 2021 12 15; 88(S1):S27-S38. Sevelius JM, Glidden DV, Deutsch M, Welborn L, Contreras A, Salinas A, Venegas L, Grant RM. PMID: 34757990; PMCID: PMC8579996.
      View in: PubMed   Mentions:
    10. PrEP Use and Adherence Among Transgender Patients. AIDS Behav. 2022 Apr; 26(4):1251-1259. Downing J, Yee K, Sevelius JM. PMID: 34643827.
      View in: PubMed   Mentions:    Fields:    
    11. The impact of COVID-19 on mentoring early-career investigators: "Everything can wait. Listen more than usual and share your own struggles". Medicine (Baltimore). 2021 Oct 08; 100(40):e27423. Johnson MO, Gandhi M, Fuchs JD, Sterling L, Sauceda JA, Saag MS, Riley ED, Sevelius JM. PMID: 34622852; PMCID: PMC8500630.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    12. Sex Hormone Therapy and Tenofovir Diphosphate Concentration in Dried Blood Spots: Primary Results of the Interactions Between Antiretrovirals And Transgender Hormones Study. Clin Infect Dis. 2021 10 05; 73(7):e2117-e2123. Grant RM, Pellegrini M, Defechereux PA, Anderson PL, Yu M, Glidden DV, O'Neal J, Yager J, Bhasin S, Sevelius J, Deutsch MB. PMID: 32766890; PMCID: PMC8492111.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    13. An Intervention by and for Transgender Women Living With HIV: Study Protocol for a Two-Arm Randomized Controlled Trial Testing the Efficacy of “Healthy Divas” to Improve HIV Care Outcomes. Frontiers in Reproductive Health. 2021. Sevelius JM, Neilands TB, Reback CJ, Castro D, Dilworth SE, Kaplan RL, Johnson MO.
    14. Evidence for the Model of Gender Affirmation: The Role of Gender Affirmation and Healthcare Empowerment in Viral Suppression Among Transgender Women of Color Living with HIV. AIDS Behav. 2021 Jul; 25(Suppl 1):64-71. Sevelius J, Chakravarty D, Neilands TB, Keatley J, Shade SB, Johnson MO, Rebchook G, HRSA SPNS Transgender Women of Color Study Group. PMID: 31144131.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    15. "She is Like a Sister to Me." Gender-Affirming Services and Relationships are Key to the Implementation of HIV Care Engagement Interventions with Transgender Women of Color. AIDS Behav. 2021 Jul; 25(Suppl 1):72-83. Maiorana A, Sevelius J, Keatley J, Rebchook G. PMID: 31912274; PMCID: PMC7223907.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. Considerations for the Design of Pre-exposure Prophylaxis (PrEP) Interventions for Women: Lessons Learned from the Implementation of a Novel PrEP Intervention. AIDS Behav. 2021 Dec; 25(12):3987-3999. Walters SM, Platt J, Anakaraonye A, Golub SA, Cunningham CO, Norton BL, Sevelius JM, Blackstock OJ. PMID: 34138377; PMCID: PMC8210500.
      View in: PubMed   Mentions: 1     Fields:    
    17. Correlates of Engagement in HIV Care Among Transgender Women of Color in the United States of America. AIDS Behav. 2021 Jul; 25(Suppl 1):3-12. Sevelius JM, Xavier J, Chakravarty D, Keatley J, Shade S, Rebchook G, SPNS Transgender Women of Color Study Group. PMID: 34037930.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Call for Special Issue Papers: Transgender Health and Corrections. J Correct Health Care. 2021 Jun; 27(2):71-72. Sevelius J, Jackson A, Harzke AJ. PMID: 34232774.
      View in: PubMed   Mentions:    Fields:    
    19. A Pilot Study to Evaluate a Novel Pre-exposure Prophylaxis Peer Outreach and Navigation Intervention for Women at High Risk for HIV Infection. AIDS Behav. 2021 May; 25(5):1411-1422. Blackstock OJ, Platt J, Golub SA, Anakaraonye AR, Norton BL, Walters SM, Sevelius JM, Cunningham CO. PMID: 32748159; PMCID: PMC8284566.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    20. Implementation Strategies for Creating Inclusive, All-Women HIV Care Environments: Perspectives From Trans and Cis Women. Womens Health Issues. 2021 Jul-Aug; 31(4):332-340. Auerbach JD, Moran L, Weber S, Watson C, Keatley J, Sevelius J. PMID: 33941451.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Health Care Experiences of Patients with Nonbinary Gender Identities. Transgender Health. 2021. Bindman J, Ngo A, Zamudio-Haas S, Sevelius J. .
    22. Measuring Satisfaction and Comfort with Gender Identity and Gender Expression among Transgender Women: Development and Validation of the Psychological Gender Affirmation Scale. Int J Environ Res Public Health. 2021 03 23; 18(6). Sevelius JM, Chakravarty D, Dilworth SE, Rebchook G, Neilands TB. PMID: 33806834; PMCID: PMC8005192.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    23. Mental Health and Psychosocial Risk and Protective Factors Among Black and Latinx Transgender Youth Compared With Peers. JAMA Netw Open. 2021 03 01; 4(3):e213256. Vance SR, Boyer CB, Glidden DV, Sevelius J. PMID: 33769506; PMCID: PMC7998078.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    24. Community Belonging and Attitudes Towards HIV Pre-Exposure Prophylaxis (PrEP) Among Transgender Women. AIDS Behav. 2021 Sep; 25(9):2728-2742. D'Avanzo PA, Bass SB, Kelly PJ, Brajuha J, Gutierrez-Mock L, Sevelius J. PMID: 33575901; PMCID: PMC8355232.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    25. Inclusion as illusion: erasing transgender women in research with MSM. J Int AIDS Soc. 2021 01; 24(1):e25661. Poteat TC, van der Merwe LLA, Sevelius J, Keatley J. PMID: 33496381; PMCID: PMC7836207.
      View in: PubMed   Mentions:    Fields:    
    26. Gender Affirmation through Correct Pronoun Usage: Development and Validation of the Transgender Women's Importance of Pronouns (TW-IP) Scale. Int J Environ Res Public Health. 2020 12 19; 17(24). Sevelius JM, Chakravarty D, Dilworth SE, Rebchook G, Neilands TB. PMID: 33352630; PMCID: PMC7766835.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    27. Housing stability and transactional sex among Spanish-speaking and English-speaking transgender women. Annals of LGBTQ+ Public and Population Health. 2020. Sauceda, J.A., Santiago-Rodriguez, E.I., Zaragoza, G., Rivas, C.E., Venegas, L., Zamudio-Haas, S., Gutierrez-Mock, L., Bass, S.B., Sevelius, JM .
    28. Couples-based approach to HIV prevention for transgender women and their partners: study protocol for a randomised controlled trial testing the efficacy of the 'It Takes Two' intervention. BMJ Open. 2020 10 15; 10(10):e038723. Gamarel KE, Sevelius JM, Neilands TB, Kaplan RL, Johnson MO, Nemoto T, Darbes LA, Operario D. PMID: 33060086; PMCID: PMC7566735.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    29. Dr. Valentina Wasson: Questioning what we think we know about the foundations of psychedelic science. Journal of Psychedelic Studies. 2020. Williams, M. T., Bartlett, A., Michaels, T., Sevelius, J., & George, J. R. View Publication.
    30. What Sexual and Gender Minority People Want Researchers to Know About Sexual Orientation and Gender Identity Questions: A Qualitative Study. Arch Sex Behav. 2020 10; 49(7):2301-2318. Suen LW, Lunn MR, Katuzny K, Finn S, Duncan L, Sevelius J, Flentje A, Capriotti MR, Lubensky ME, Hunt C, Weber S, Bibbins-Domingo K, Obedin-Maliver J. PMID: 32875381; PMCID: PMC7497435.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    31. We Are All Women: Barriers and Facilitators to Inclusion of Transgender Women in HIV Treatment and Support Services Designed for Cisgender Women. AIDS Patient Care STDS. 2020 09; 34(9):392-398. Auerbach JD, Moran L, Watson C, Weber S, Keatley J, Sevelius J. PMID: 32813571; PMCID: PMC7480717.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    32. HIV Testing and PrEP Use in a National Probability Sample of Sexually Active Transgender People in the United States. J Acquir Immune Defic Syndr. 2020 08 15; 84(5):437-442. Sevelius JM, Poteat T, Luhur WE, Reisner SL, Meyer IH. PMID: 32692101; PMCID: PMC7340231.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsPHPublic Health
    33. Research with Marginalized Communities: Challenges to Continuity During the COVID-19 Pandemic. AIDS Behav. 2020 07; 24(7):2009-2012. Sevelius JM, Gutierrez-Mock L, Zamudio-Haas S, McCree B, Ngo A, Jackson A, Clynes C, Venegas L, Salinas A, Herrera C, Stein E, Operario D, Gamarel K. PMID: 32415617; PMCID: PMC7228861.
      View in: PubMed   Mentions: 8     Fields:    
    34. Sheroes: Feasibility and Acceptability of a Community-Driven, Group-Level HIV Intervention Program for Transgender Women. AIDS Behav. 2020 May; 24(5):1551-1559. Sevelius JM, Neilands TB, Dilworth S, Castro D, Johnson MO. PMID: 31562572.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    35. Translating research into practice to close the health disparity gap in the LGBTQIA+ community. Annals of Behavioral Medicine. 2020; (54):S451-S45. Wiklund, L. O., Anderson-Carpenter, K. D., Sevelius, J. M., Ching, T., & Buchanan, N. T. View Publication.
    36. Longitudinal cohort of HIV-negative transgender women of colour in New York City: protocol for the TURNNT ('Trying to Understand Relationships, Networks and Neighbourhoods among Transgender women of colour') study. BMJ Open. 2020 04 01; 10(4):e032876. Callander D, Schneider JA, Radix A, Chaix B, Scheinmann R, Love G, Smith J, Regan SD, Kawachi I, St James K, Ransome Y, Herrera C, Reisner SL, Doroshow C, Poteat T, Watson K, Bluebond-Langner R, Toussaint N, Garofalo R, Sevelius J, Duncan DT. PMID: 32241785; PMCID: PMC7170618.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    37. Identifying Opportunities for Collaboration Across the Social Sciences to Reach the 10-10-10: A Multilevel Approach. J Acquir Immune Defic Syndr. 2019 12 01; 82 Suppl 2:S118-S123. Vincent W, Sevelius J, Lippman SA, Linnemayr S, Arnold EA. PMID: 31658198; PMCID: PMC6820711.
      View in: PubMed   Mentions: 3  Translation:Humans
    38. Relationship Stigma and HIV Risk Behavior Among Cisgender Men Partnered with Transgender Women: The Moderating Role of Sexual Identity. Arch Sex Behav. 2020 01; 49(1):175-184. Gamarel KE, Sevelius JM, Reisner SL, Richardson RL, Darbes LA, Nemoto T, Operario D. PMID: 31586272; PMCID: PMC7018566.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    39. "Some of us, we don't know where we're going to be tomorrow." Contextual factors affecting PrEP use and adherence among a diverse sample of transgender women in San Francisco. AIDS Care. 2020 05; 32(5):585-593. Cahill SR, Keatley J, Wade Taylor S, Sevelius J, Elsesser SA, Geffen SR, Wang T, Mayer KH. PMID: 31482726.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    40. Developing Correctional Policy, Practice, and Clinical Care Considerations for Incarcerated Transgender Patients Through Collaborative Stakeholder Engagement. J Correct Health Care. 2019 07; 25(3):277-286. Kendig NE, Cubitt A, Moss A, Sevelius J. PMID: 31242806.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    41. The Psychedelic Renaissance and the limitations of a White-dominant medical framework. Journal of Psychedelic Studies. 2019. George, J.R., Michaels, T.I., Sevelius, J.M., Williams, M. View Publication.
    42. Medical Mistrust and PrEP Perceptions Among Transgender Women: A Cluster Analysis. Behav Med. 2019 Apr-Jun; 45(2):143-152. D'Avanzo PA, Bass SB, Brajuha J, Gutierrez-Mock L, Ventriglia N, Wellington C, Sevelius J. PMID: 31343968; PMCID: PMC6943929.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    43. Psychedelic-Assisted Therapy with Transgender and Gender Diverse Individuals. Bulletin of the Multidisciplinary Association for Psychedelic Studies, Special Edition: Women & Psychedelics. 2019; 1(24):39-42. Sevelius, J.
    44. Optimising HIV programming for transgender women in Brazil. Cult Health Sex. 2019 05; 21(5):543-558. Sevelius J, Murray LR, Martinez Fernandes N, Veras MA, Grinsztejn B, Lippman SA. PMID: 30378463; PMCID: PMC6483864.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    45. Commitment, interpersonal stigma, and mental health in romantic relationships between transgender women and cisgender male partners. J Soc Pers Relat. 2019 Jul; 36(7):2180-2201. Gamarel KE, Sevelius JM, Reisner SL, Coats CS, Nemoto T, Operario D. PMID: 31086428; PMCID: PMC6510026.
      View in: PubMed   Mentions: 3  
    46. From erasure to opportunity: a qualitative study of the experiences of transgender men around pregnancy and recommendations for providers. BMC Pregnancy Childbirth. 2017 Nov 08; 17(Suppl 2):332. Hoffkling A, Obedin-Maliver J, Sevelius J. PMID: 29143629; PMCID: PMC5688401.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    47. Challenges and opportunities for gender-affirming healthcare for transgender women in prison. Int J Prison Health. 2017 03 13; 13(1):32-40. Sevelius J, Jenness V. PMID: 28299969; PMCID: PMC8263052.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    48. Transgender Population Size in the United States: a Meta-Regression of Population-Based Probability Samples. Am J Public Health. 2017 Feb; 107(2):216. Meerwijk EL, Sevelius JM. PMID: 28075643.
      View in: PubMed   Mentions:
    49. Transgender Population Size in the United States: a Meta-Regression of Population-Based Probability Samples. Am J Public Health. 2017 02; 107(2):e1-e8. Meerwijk EL, Sevelius JM. PMID: 28075632; PMCID: PMC5227946.
      View in: PubMed   Mentions:
    50. The Transgender Women of Color Initiative: Implementing and Evaluating Innovative Interventions to Enhance Engagement and Retention in HIV Care. American Journal of Public Health. 2017. Rebchook G, Keatley J, Contreras R, Perloff J, Molano LF, Reback CJ, Ducheny K, Nemoto T, Lin R, Birnbaum J, Woods T, Xavier J; SPNS Transgender Women of Color Study Group.
    51. The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices. J Int AIDS Soc. 2016; 19(7(Suppl 6)):21105. Sevelius JM, Deutsch MB, Grant R. PMID: 27760683; PMCID: PMC5071750.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansPHPublic Health
    52. Transgender Women in Clinical Trials of Pre-Exposure Prophylaxis. J Acquir Immune Defic Syndr. 2016 08 15; 72 Suppl 3:S226-9. Grant RM, Sevelius JM, Guanira JV, Aguilar JV, Chariyalertsak S, Deutsch MB. PMID: 27429187; PMCID: PMC4969062.
      View in: PubMed   Mentions: 17  Translation:HumansPHPublic Health
    53. Transgender women, hormonal therapy and HIV treatment: a comprehensive review of the literature and recommendations for best practices. J Int AIDS Soc. 2016; 19(3 Suppl 2):20810. Radix A, Sevelius J, Deutsch MB. PMID: 27431475; PMCID: PMC4949308.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    54. PrEP adherence among trans women in Brazil-access needed for this key population - Authors' reply. Lancet HIV. 2016 05; 3(5):e200-1. Sevelius J, Deutsch MB, Glidden DV, Grant RM. PMID: 27126486.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    55. 'You should build yourself up as a whole product': Transgender female identity in Lima, Peru. Glob Public Health. 2016 Aug-Sep; 11(7-8):981-93. Pollock L, Silva-Santisteban A, Sevelius J, Salazar X. PMID: 27080150.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    56. Acceptability and Feasibility of HIV Self-Testing Among Transgender Women in San Francisco: A Mixed Methods Pilot Study. AIDS Behav. 2016 Apr; 20(4):928-38. Lippman SA, Moran L, Sevelius J, Castillo LS, Ventura A, Treves-Kagan S, Buchbinder S. PMID: 26511864; PMCID: PMC4799740.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansPHPublic Health
    57. Adult development and quality of life of transgender and gender nonconforming people. Curr Opin Endocrinol Diabetes Obes. 2016 Apr; 23(2):188-97. Bockting W, Coleman E, Deutsch MB, Guillamon A, Meyer I, Meyer W, Reisner S, Sevelius J, Ettner R. PMID: 26835800; PMCID: PMC4809047.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    58. Barriers to healthcare for transgender individuals. Curr Opin Endocrinol Diabetes Obes. 2016 Apr; 23(2):168-71. Safer JD, Coleman E, Feldman J, Garofalo R, Hembree W, Radix A, Sevelius J. PMID: 26910276; PMCID: PMC4802845.
      View in: PubMed   Mentions: 105     Fields:    Translation:Humans
    59. 'I am not a man': Trans-specific barriers and facilitators to PrEP acceptability among transgender women. Glob Public Health. 2016 Aug-Sep; 11(7-8):1060-75. Sevelius JM, Keatley J, Calma N, Arnold E. PMID: 26963756.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansPHPublic Health
    60. In the name of brevity: The problem with binary HIV risk categories. Glob Public Health. 2016 Aug-Sep; 11(7-8):824-34. Kaplan RL, Sevelius J, Ribeiro K. PMID: 26824592; PMCID: PMC5140888.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    61. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial. Lancet HIV. 2015 Dec; 2(12):e512-9. Deutsch MB, Glidden DV, Sevelius J, Keatley J, McMahan V, Guanira J, Kallas EG, Chariyalertsak S, Grant RM, iPrEx investigators. PMID: 26614965; PMCID: PMC5111857.
      View in: PubMed   Mentions: 90     Fields:    Translation:HumansPHPublic Health
    62. Syndemics and gender affirmation: HIV sexual risk in female-to-male trans masculine adults reporting sexual contact with cisgender males. Int J STD AIDS. 2016 10; 27(11):955-66. Reisner SL, White Hughto JM, Pardee D, Sevelius J. PMID: 26384946; PMCID: PMC4798921.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    63. Transgender men who experienced pregnancy after female-to-male gender transitioning. Obstet Gynecol. 2014 Dec; 124(6):1120-1127. Light AD, Obedin-Maliver J, Sevelius JM, Kerns JL. PMID: 25415163.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    64. Transgender Issues in HIV. HIV Specialist: Patient Care, Practice Management, and Professional Information for HIV Care Providers. American Academy of HIV Medicine. 2014. Sevelius, J.
    65. Becoming Janet Mock. [Review of the book Redefining realness: My path to womanhood, identity, love and so much more., by J. Mock]. PsychCRITIQUES. 2014; 51(59). Sevelius, J., Sa’id, A., Warri, V. View Publication.
    66. Collection of gender identity data using electronic medical records: survey of current end-user practices. J Assoc Nurses AIDS Care. 2014 Nov-Dec; 25(6):657-63. Deutsch MB, Keatley J, Sevelius J, Shade SB. PMID: 24880490.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    67. Correlates of antiretroviral adherence and viral load among transgender women living with HIV. AIDS Care. 2014; 26(8):976-82. Sevelius JM, Saberi P, Johnson MO. PMID: 24646419; PMCID: PMC4054817.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    68. Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus. Ann Behav Med. 2014 Feb; 47(1):5-16. Sevelius JM, Patouhas E, Keatley JG, Johnson MO. PMID: 24317955; PMCID: PMC3925767.
      View in: PubMed   Mentions: 119     Fields:    Translation:Humans
    69. Racial/ethnic disparities in history of incarceration, experiences of victimization, and associated health indicators among transgender women in the U.S. Women Health. 2014; 54(8):750-67. Reisner SL, Bailey Z, Sevelius J. PMID: 25190135; PMCID: PMC5441521.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    70. Gender Affirmation: A Framework for Conceptualizing Risk Behavior among Transgender Women of Color. Sex Roles. 2013 Jun 01; 68(11-12):675-689. Sevelius JM. PMID: 23729971; PMCID: PMC3667985.
      View in: PubMed   Mentions: 128  
    71. Transgender women of color: discrimination and depression symptoms. Ethn Inequal Health Soc Care. 2013; 6(4):121-136. Jefferson K, Neilands TB, Sevelius J. PMID: 25346778; PMCID: PMC4205968.
      View in: PubMed   Mentions: 15  
    72. HIV Prevention in Transgender Persons. Encyclopedia of AIDS. 2012. Sevelius, J. & Johnson, M.O.
    73. Preliminary support for the construct of health care empowerment in the context of treatment for human immunodeficiency virus. Patient Prefer Adherence. 2012; 6:395-404. Johnson MO, Sevelius JM, Dilworth SE, Saberi P, Neilands TB. PMID: 22654510; PMCID: PMC3363300.
      View in: PubMed   Mentions: 17  
    74. HIV/AIDS programming in the United States: considerations affecting transgender women and girls. Womens Health Issues. 2011 Nov; 21(6 Suppl):S278-82. Sevelius JM, Keatley J, Gutierrez-Mock L. PMID: 22055679; PMCID: PMC5441541.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansPHPublic Health
    75. Antiretroviral therapy adherence among transgender women living with HIV. J Assoc Nurses AIDS Care. 2010 May-Jun; 21(3):256-64. Sevelius JM, Carrico A, Johnson MO. PMID: 20347342; PMCID: PMC2859994.
      View in: PubMed   Mentions: 62     Fields:    Translation:Humans
    76. "There's no pamphlet for the kind of sex I have": HIV-related risk factors and protective behaviors among transgender men who have sex with nontransgender men. J Assoc Nurses AIDS Care. 2009 Sep-Oct; 20(5):398-410. Sevelius J. PMID: 19732698; PMCID: PMC2785444.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    77. Informing interventions: the importance of contextual factors in the prediction of sexual risk behaviors among transgender women. AIDS Educ Prev. 2009 Apr; 21(2):113-27. Sevelius JM, Reznick OG, Hart SL, Schwarcz S. PMID: 19397434; PMCID: PMC4535696.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    78. Student responsiveness to women's and gender studies classes: The importance of initial student attitudes and classroom relationships. NWSA Journal. 2008; 2(20):189-215. Stake, J.E., Sevelius, J.M., Hanly, S.
    79. Men who have sex with transgender women: challenges to category-based HIV prevention. AIDS Behav. 2008 Jan; 12(1):18-26. Operario D, Burton J, Underhill K, Sevelius J. PMID: 17705095.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    80. The effects of prior attitudes and attitude importance on attitude change and class impact in women’s and gender studies. Journal of Applied Social Psychology. 2003; (33):2341 – 2353. Sevelius, J.M. & Stake, J.E.
    Jae's Networks
    Concepts (177)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (30)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.1.0-871-g21b54b14 on PROFILES-PWEB01.

    Copyright © The Regents of the University of California